Gliclazide Enhances Exercise Performance and Recovery of Muscle Strength in Healthy Trained Individuals: A Randomized Controlled Trial
European Journal of Sport Science · 2026-04 · 26 (4)
DOI: 10.1002/ejsc.70155 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Sport Science, online erschienen am 12.03.2026. Verfasst von Jocelito Bijoldo Martins und 3 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Cardiologia do Rio Grande do Sul/Fundação Universitária de Cardiologia, Porto Alegre, RS, Brazil. Hauptthemen laut MEDLINE: Muscle Strength, Gliclazide, Resistance Training, Athletic Performance. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
To examine the acute effect of gliclazide on exercise performance and recovery of muscle strength in healthy participants. We conducted a randomized, double‐blind, placebo‐controlled crossover clinical trial in 44 strength‐trained men. They were allocated to gliclazide modified release (MR) (90 mg, 8h before exercise sessions) or placebo, undergo three consecutive sessions of strength exercise (four sets, 80% of one‐repetition maximum [1‐RM] of bench press and free squat exercise). We evaluated total volume‐load (VL) (#repetitions x 80%1‐RM), range of motion (ROM), insulin and glucose levels, creatine kinase MM (CK‐MM), lactate dehydrogenase (LDH), interleukin‐6 (IL‐6) and tumor necrosis factor alpha (TNF‐α), hemodynamic parameters, perceived muscle soreness and recovery scores. Gliclazide enhanced strength exercise performance with improvements in total VL (bench press 23.3%, p < 0.001; squat 23.2%, p < 0.001), and improved muscle recovery 24–48h post‐exercise: ROM (shoulder 1.1%, p < 0.001; knee 1.6%, p = 0.004), CK‐MM (−13.2%, p < 0.001), LDH (−12.8%, p < 0.001), TNF‐α (−17.4%, p < 0.001), IL‐6 (−5.3%, p < 0.001), muscle soreness (−17.7%, p < 0.001) and recovery scores (32.5%, p = 0.001). However, hypoglycemia events were observed in 3 participants in the gliclazide group. In conclusion, Gliclazide MR 90 mg, 8h before strength exercise, produced ergogenic effects (exercise performance and muscle recovery), although hypoglycemia was observed in 7% of subjects. Registration : “ www.clinicaltrials.gov ”, “NCT04443777” (Primary Completion: 01/08/2020; Study Completion: 31/10/2023)
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Cardiologia do Rio Grande do Sul/Fundação Universitária de Cardiologia, Porto Alegre, RS, Brazil.
- Programa de Pos-Graduação em Saúde Coletiva, Universidade do Vale do Rio dos Sinos, São Leopoldo, Rio Grande do Sul, Brazil.
- Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil.
- Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
ORCID-Profile: Alexandre Machado Lehnen
Zitieren
APA
Martins, J. B., Dipp, T., Schaan, B. D., & Lehnen, A. M. (2026). Gliclazide Enhances Exercise Performance and Recovery of Muscle Strength in Healthy Trained Individuals: A Randomized Controlled Trial. European Journal of Sport Science, 26(4). https://doi.org/10.1002/ejsc.70155
Vancouver
Martins JB, Dipp T, Schaan BD, Lehnen AM. Gliclazide Enhances Exercise Performance and Recovery of Muscle Strength in Healthy Trained Individuals: A Randomized Controlled Trial. European Journal of Sport Science. 2026;26(4). doi:10.1002/ejsc.70155
BibTeX
@article{Martins2026,
author = {Martins, Jocelito Bijoldo and Dipp, Thiago and Schaan, Beatriz D and Lehnen, Alexandre Machado},
title = {Gliclazide Enhances Exercise Performance and Recovery of Muscle Strength in Healthy Trained Individuals: A Randomized Controlled Trial},
journal = {European Journal of Sport Science},
year = {2026},
volume = {26},
number = {4},
doi = {10.1002/ejsc.70155}
}
EUVIMED